GSK Slams SG's Call To Tackle Skinny Labels At High Court
GlaxoSmithKline has challenged the U.S. solicitor general's take on the drugmaker's high court dispute with rival Teva Pharmaceuticals over a generic version of heart drug Coreg, arguing Tuesday that the government...To view the full article, register now.
Already a subscriber? Click here to view full article